Biohaven Ltd. (BHVN)

Biohaven Ltd. (BHVN) is a healthcare company (biotechnology) based in the United States. The share price is $13.24, down 4.06% on the day, which values the company at $2B. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$13.24−4.06% today
Market value
$2B
200-week average
$24.7246% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Biohaven Ltd. in more detail

BHVN trades at -8.6× next year's expected earnings. It sits 46% below its 200-week average of $24.72.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Biohaven Ltd. (BHVN): questions and answers

What is Biohaven Ltd.'s market cap?

Biohaven Ltd. is valued at $2B at a share price of $13.24.

Is BHVN above its 200-week moving average?

No. BHVN is 46.4% below its 200-week average of $24.72. Long-term investors watch that line because strong companies rarely trade below it for long.

Does BHVN pay a dividend?

Biohaven Ltd. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Biohaven Ltd. (BHVN) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/BHVN

Underlying data: Yahoo Finance; company filings with the SEC.